Stability and degradation of fibroblast growth factor 23 (FGF23): the effect of time and temperature and assay type

Method-specific differences in plasma fibroblast growth factor 23 measurement using four commercial ELISAs

(2013) Edward R. Smith et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia

(2013) Young H. Lim et al.   HUMAN MOLECULAR GENETICS

Tumor localization and biochemical response to cure in tumor-induced osteomalacia

(2013) William H Chong et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Biological Variability of Plasma Intact and C-Terminal FGF23 Measurements

(2012) Edward R. Smith et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Fibroblast growth factor 23: state of the field and future directions

(2012) Nisan Bhattacharyya et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Instability of fibroblast growth factor-23 (FGF-23): Implications for clinical studies

(2011) Edward R. Smith et al.   CLINICA CHIMICA ACTA

Autosomal-Recessive Hypophosphatemic Rickets Is Associated with an Inactivation Mutation in the ENPP1 Gene

(2010) Varda Levy-Litan et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Small Integrin-Binding Proteins as Serum Markers for Prostate Cancer Detection

(2009) A. Jain et al.   CLINICAL CANCER RESEARCH

Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active

(2009) Takashi Shimada et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM